In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 Gram-positive blood culture isolates
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (2) , 143-147
- https://doi.org/10.1016/0732-8893(89)90005-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Corynebacterium jeikeium (Group JK) resistence to ciprofloxacin emerging during therapyJournal of Antimicrobial Chemotherapy, 1987
- Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapyAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- CIPROFLOXACIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1985
- Review of the in vitro spectrum of activity of imipenemThe American Journal of Medicine, 1985
- Gram-positive superinfections following beta-lactam chemotherapy: The significance of the enterococcusInfection, 1985
- Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro CharacteristicsClinical Infectious Diseases, 1983
- A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsJournal of Antimicrobial Chemotherapy, 1983
- Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of SynergyClinical Infectious Diseases, 1982
- GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activityAntimicrobial Agents and Chemotherapy, 1980